BE563791A - - Google Patents

Info

Publication number
BE563791A
BE563791A BE563791DA BE563791A BE 563791 A BE563791 A BE 563791A BE 563791D A BE563791D A BE 563791DA BE 563791 A BE563791 A BE 563791A
Authority
BE
Belgium
Prior art keywords
histamine
composition
globulin
gamma
acid
Prior art date
Application number
Other languages
English (en)
French (fr)
Publication of BE563791A publication Critical patent/BE563791A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE563791D BE563791A (de)

Publications (1)

Publication Number Publication Date
BE563791A true BE563791A (de)

Family

ID=184899

Family Applications (1)

Application Number Title Priority Date Filing Date
BE563791D BE563791A (de)

Country Status (1)

Country Link
BE (1) BE563791A (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0094575A3 (en) * 1982-05-17 1984-10-10 University Patents, Inc. Methods and materials for treatment of disease states involving immunological factors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0094575A3 (en) * 1982-05-17 1984-10-10 University Patents, Inc. Methods and materials for treatment of disease states involving immunological factors

Similar Documents

Publication Publication Date Title
AU619930B2 (en) Use of resiniferatoxin and analogues thereof to cause sensory afferent c-fiber and thermoregulatory desensitization
EP0414608B1 (de) Neue kosmetische Präparate die Chitosan und Glucosamin enthalten
DE69933738T2 (de) Zusammensetzung, welche Aminosäuren und Trehalose enthält
US20030224938A1 (en) Enhanced herbicides
EP1937228A1 (de) Auf einem morpholin-antimykotikum basierende pharmazeutische zusammensetzung und wasserlöslichen film bildendes mittel zur anwendung auf dem nagel und um den nagel
FR2758720A1 (fr) Compositions cosmetiques de soins capillaires avec effet de suppression de formation de pellicules
EP1464330B1 (de) Antiallergische Zusammensetzung, die OLIGOSACCHARIDe und eine Saponine oder eine basische Aminosäure enthält, zur topischen Verabreichung oder Inhalation
US6660304B2 (en) Method of treating prickly heat
Khan et al. The effect of nitric oxide and peroxynitrite on rabbit cavernosal smooth muscle relaxation
US7008963B2 (en) Urushiol induced contact dermatitis solution
BE563791A (de)
Macrides et al. Hepatoprotective effects of the shark bile salt 5β-scymnol on acetaminophen-induced liver damage in mice
WO1999027902A1 (fr) Composition comportant un n-undecylenoyl aminoacide; application en cosmetique
EP0768887B1 (de) Kompositionen mit antiviralen wirkungen und verfahren zur herstellung
JPH04124140A (ja) アンジオテンシン変換酵素阻害剤
CA2083825A1 (fr) Nouvelle composition pharmaceutique a base de taurine pour l'administration par inhalation
TW200404567A (en) Stabilised topical formulations containing ketoprofen
El-Alfy et al. Amelioration of the cardiovascular manifestations of the yellow scorpion Leiurus quinquestriatus envenomation in rats by red grape seeds proanthocyanidins
EP0618794B1 (de) Verwendung von 4-[(2-oxo-3-bornylidene)methyl]-fenyltrimethylammonium methylsulfat in einer zusammensetzung zur dauerhaften verformung
WO2005094806A1 (en) Use of quaternary ammonium compounds as specific blockers of transport through aquaporin, compositions comprising the compounds and method of selecting the compounds
Ay et al. Effects of androctonus crassicauda scorpion venom on endothelium-dependent and-independent vascular responses of rabbit aorta
US20040152682A1 (en) Stabilized steroid composition and method for its preparation
FR2814075A1 (fr) Pommade nasale a base de vaseline et de tannis
Ujváry et al. Role of β-alanine in pupal cuticle coloration in the tobacco hornworm, Manduca sexta: Effects of β-alanine analogues on melanization and catecholamine levels
EP1425296A1 (de) Organische verbindungen mit biologischer wirkung als thrombinhemmer und ihre verwendung